nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepotastine—Lip swelling—Bortezomib—hematologic cancer	0.0795	0.081	CcSEcCtD
Bepotastine—Eye irritation—Nilotinib—hematologic cancer	0.0202	0.0206	CcSEcCtD
Bepotastine—Eye irritation—Imatinib—hematologic cancer	0.0201	0.0205	CcSEcCtD
Bepotastine—Eye irritation—Lenalidomide—hematologic cancer	0.0175	0.0179	CcSEcCtD
Bepotastine—Eye irritation—Bortezomib—hematologic cancer	0.0161	0.0164	CcSEcCtD
Bepotastine—Eye irritation—Alitretinoin—hematologic cancer	0.0139	0.0141	CcSEcCtD
Bepotastine—Eye irritation—Ifosfamide—hematologic cancer	0.0137	0.0139	CcSEcCtD
Bepotastine—Nasopharyngitis—Nilotinib—hematologic cancer	0.0112	0.0114	CcSEcCtD
Bepotastine—Nasopharyngitis—Imatinib—hematologic cancer	0.0112	0.0114	CcSEcCtD
Bepotastine—Eye irritation—Prednisolone—hematologic cancer	0.0107	0.0109	CcSEcCtD
Bepotastine—Haloperidol—H1F0—hematologic cancer	0.0101	0.544	CrCbGaD
Bepotastine—Pruritus—Ruxolitinib—hematologic cancer	0.01	0.0102	CcSEcCtD
Bepotastine—Nasopharyngitis—Lenalidomide—hematologic cancer	0.00972	0.00991	CcSEcCtD
Bepotastine—Nasopharyngitis—Bortezomib—hematologic cancer	0.00895	0.00912	CcSEcCtD
Bepotastine—Headache—Ruxolitinib—hematologic cancer	0.00887	0.00903	CcSEcCtD
Bepotastine—Pruritus—Vorinostat—hematologic cancer	0.00846	0.00862	CcSEcCtD
Bepotastine—Nasopharyngitis—Alitretinoin—hematologic cancer	0.00768	0.00782	CcSEcCtD
Bepotastine—Hypersensitivity—Mechlorethamine—hematologic cancer	0.00757	0.00771	CcSEcCtD
Bepotastine—Headache—Vorinostat—hematologic cancer	0.00749	0.00763	CcSEcCtD
Bepotastine—Pruritus—Mechlorethamine—hematologic cancer	0.00727	0.00741	CcSEcCtD
Bepotastine—Nasopharyngitis—Cisplatin—hematologic cancer	0.00654	0.00667	CcSEcCtD
Bepotastine—Rash—Mechlorethamine—hematologic cancer	0.00648	0.0066	CcSEcCtD
Bepotastine—Dermatitis—Mechlorethamine—hematologic cancer	0.00647	0.00659	CcSEcCtD
Bepotastine—Hypersensitivity—Methoxsalen—hematologic cancer	0.00624	0.00635	CcSEcCtD
Bepotastine—Hypersensitivity—Mercaptopurine—hematologic cancer	0.00606	0.00617	CcSEcCtD
Bepotastine—Pruritus—Methoxsalen—hematologic cancer	0.00599	0.0061	CcSEcCtD
Bepotastine—Hypersensitivity—Clofarabine—hematologic cancer	0.00597	0.00609	CcSEcCtD
Bepotastine—Hypersensitivity—Daunorubicin—hematologic cancer	0.00597	0.00609	CcSEcCtD
Bepotastine—Hypersensitivity—Pentostatin—hematologic cancer	0.00595	0.00606	CcSEcCtD
Bepotastine—Pruritus—Clofarabine—hematologic cancer	0.00574	0.00585	CcSEcCtD
Bepotastine—Pruritus—Daunorubicin—hematologic cancer	0.00574	0.00585	CcSEcCtD
Bepotastine—Hypersensitivity—Idarubicin—hematologic cancer	0.00574	0.00584	CcSEcCtD
Bepotastine—Pruritus—Pentostatin—hematologic cancer	0.00571	0.00582	CcSEcCtD
Bepotastine—Pruritus—Anagrelide—hematologic cancer	0.00571	0.00582	CcSEcCtD
Bepotastine—Hypersensitivity—Teniposide—hematologic cancer	0.00558	0.00569	CcSEcCtD
Bepotastine—Headache—Nelarabine—hematologic cancer	0.00543	0.00553	CcSEcCtD
Bepotastine—Pruritus—Teniposide—hematologic cancer	0.00536	0.00546	CcSEcCtD
Bepotastine—Rash—Methoxsalen—hematologic cancer	0.00534	0.00544	CcSEcCtD
Bepotastine—Dermatitis—Methoxsalen—hematologic cancer	0.00533	0.00543	CcSEcCtD
Bepotastine—Headache—Methoxsalen—hematologic cancer	0.0053	0.0054	CcSEcCtD
Bepotastine—Rash—Mercaptopurine—hematologic cancer	0.00518	0.00528	CcSEcCtD
Bepotastine—Dermatitis—Mercaptopurine—hematologic cancer	0.00518	0.00528	CcSEcCtD
Bepotastine—Hypersensitivity—Busulfan—hematologic cancer	0.00517	0.00527	CcSEcCtD
Bepotastine—Rash—Clofarabine—hematologic cancer	0.00511	0.00521	CcSEcCtD
Bepotastine—Rash—Daunorubicin—hematologic cancer	0.00511	0.00521	CcSEcCtD
Bepotastine—Dermatitis—Clofarabine—hematologic cancer	0.00511	0.0052	CcSEcCtD
Bepotastine—Dermatitis—Daunorubicin—hematologic cancer	0.00511	0.0052	CcSEcCtD
Bepotastine—Rash—Pentostatin—hematologic cancer	0.00509	0.00519	CcSEcCtD
Bepotastine—Rash—Anagrelide—hematologic cancer	0.00509	0.00519	CcSEcCtD
Bepotastine—Dermatitis—Anagrelide—hematologic cancer	0.00509	0.00518	CcSEcCtD
Bepotastine—Dermatitis—Pentostatin—hematologic cancer	0.00509	0.00518	CcSEcCtD
Bepotastine—Headache—Clofarabine—hematologic cancer	0.00508	0.00518	CcSEcCtD
Bepotastine—Headache—Daunorubicin—hematologic cancer	0.00508	0.00518	CcSEcCtD
Bepotastine—Headache—Pentostatin—hematologic cancer	0.00506	0.00515	CcSEcCtD
Bepotastine—Headache—Anagrelide—hematologic cancer	0.00506	0.00515	CcSEcCtD
Bepotastine—Hypersensitivity—Procarbazine—hematologic cancer	0.00502	0.00511	CcSEcCtD
Bepotastine—Pruritus—Busulfan—hematologic cancer	0.00497	0.00506	CcSEcCtD
Bepotastine—Hypersensitivity—Dasatinib—hematologic cancer	0.00492	0.00501	CcSEcCtD
Bepotastine—Hypersensitivity—Bexarotene—hematologic cancer	0.00492	0.00501	CcSEcCtD
Bepotastine—Rash—Idarubicin—hematologic cancer	0.00491	0.005	CcSEcCtD
Bepotastine—Dermatitis—Idarubicin—hematologic cancer	0.0049	0.005	CcSEcCtD
Bepotastine—Hypersensitivity—Fludarabine—hematologic cancer	0.0049	0.005	CcSEcCtD
Bepotastine—Headache—Idarubicin—hematologic cancer	0.00488	0.00497	CcSEcCtD
Bepotastine—Pruritus—Procarbazine—hematologic cancer	0.00482	0.00491	CcSEcCtD
Bepotastine—Rash—Teniposide—hematologic cancer	0.00478	0.00487	CcSEcCtD
Bepotastine—Dermatitis—Teniposide—hematologic cancer	0.00477	0.00486	CcSEcCtD
Bepotastine—Headache—Teniposide—hematologic cancer	0.00474	0.00483	CcSEcCtD
Bepotastine—Pruritus—Bexarotene—hematologic cancer	0.00472	0.00481	CcSEcCtD
Bepotastine—Pruritus—Dasatinib—hematologic cancer	0.00472	0.00481	CcSEcCtD
Bepotastine—Pruritus—Fludarabine—hematologic cancer	0.00471	0.0048	CcSEcCtD
Bepotastine—Hypersensitivity—Chlorambucil—hematologic cancer	0.00465	0.00473	CcSEcCtD
Bepotastine—Hypersensitivity—Nilotinib—hematologic cancer	0.00454	0.00463	CcSEcCtD
Bepotastine—Hypersensitivity—Imatinib—hematologic cancer	0.00452	0.0046	CcSEcCtD
Bepotastine—Pruritus—Chlorambucil—hematologic cancer	0.00446	0.00455	CcSEcCtD
Bepotastine—Hypersensitivity—Cladribine—hematologic cancer	0.00444	0.00452	CcSEcCtD
Bepotastine—Rash—Busulfan—hematologic cancer	0.00443	0.00451	CcSEcCtD
Bepotastine—Dermatitis—Busulfan—hematologic cancer	0.00442	0.0045	CcSEcCtD
Bepotastine—Headache—Busulfan—hematologic cancer	0.0044	0.00448	CcSEcCtD
Bepotastine—Pruritus—Nilotinib—hematologic cancer	0.00436	0.00445	CcSEcCtD
Bepotastine—Pruritus—Imatinib—hematologic cancer	0.00434	0.00442	CcSEcCtD
Bepotastine—Rash—Procarbazine—hematologic cancer	0.00429	0.00437	CcSEcCtD
Bepotastine—Dermatitis—Procarbazine—hematologic cancer	0.00429	0.00437	CcSEcCtD
Bepotastine—Headache—Procarbazine—hematologic cancer	0.00427	0.00435	CcSEcCtD
Bepotastine—Pruritus—Cladribine—hematologic cancer	0.00426	0.00434	CcSEcCtD
Bepotastine—Hypersensitivity—Vinblastine—hematologic cancer	0.00426	0.00434	CcSEcCtD
Bepotastine—Rash—Bexarotene—hematologic cancer	0.00421	0.00429	CcSEcCtD
Bepotastine—Rash—Dasatinib—hematologic cancer	0.00421	0.00429	CcSEcCtD
Bepotastine—Dermatitis—Dasatinib—hematologic cancer	0.0042	0.00428	CcSEcCtD
Bepotastine—Dermatitis—Bexarotene—hematologic cancer	0.0042	0.00428	CcSEcCtD
Bepotastine—Rash—Fludarabine—hematologic cancer	0.0042	0.00428	CcSEcCtD
Bepotastine—Dermatitis—Fludarabine—hematologic cancer	0.00419	0.00427	CcSEcCtD
Bepotastine—Headache—Dasatinib—hematologic cancer	0.00418	0.00426	CcSEcCtD
Bepotastine—Headache—Bexarotene—hematologic cancer	0.00418	0.00426	CcSEcCtD
Bepotastine—Headache—Fludarabine—hematologic cancer	0.00417	0.00425	CcSEcCtD
Bepotastine—Hypersensitivity—Melphalan—hematologic cancer	0.00405	0.00413	CcSEcCtD
Bepotastine—Hypersensitivity—Lenalidomide—hematologic cancer	0.00394	0.00401	CcSEcCtD
Bepotastine—Pruritus—Melphalan—hematologic cancer	0.00389	0.00396	CcSEcCtD
Bepotastine—Rash—Nilotinib—hematologic cancer	0.00389	0.00396	CcSEcCtD
Bepotastine—Dermatitis—Nilotinib—hematologic cancer	0.00388	0.00396	CcSEcCtD
Bepotastine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00388	0.00396	CcSEcCtD
Bepotastine—Rash—Imatinib—hematologic cancer	0.00387	0.00394	CcSEcCtD
Bepotastine—Headache—Nilotinib—hematologic cancer	0.00386	0.00394	CcSEcCtD
Bepotastine—Dermatitis—Imatinib—hematologic cancer	0.00386	0.00394	CcSEcCtD
Bepotastine—Headache—Imatinib—hematologic cancer	0.00384	0.00391	CcSEcCtD
Bepotastine—Rash—Cladribine—hematologic cancer	0.0038	0.00387	CcSEcCtD
Bepotastine—Dermatitis—Cladribine—hematologic cancer	0.0038	0.00387	CcSEcCtD
Bepotastine—Pruritus—Lenalidomide—hematologic cancer	0.00378	0.00385	CcSEcCtD
Bepotastine—Headache—Cladribine—hematologic cancer	0.00377	0.00385	CcSEcCtD
Bepotastine—Hypersensitivity—Bortezomib—hematologic cancer	0.00362	0.00369	CcSEcCtD
Bepotastine—Headache—Vinblastine—hematologic cancer	0.00362	0.00369	CcSEcCtD
Bepotastine—Hypersensitivity—Bleomycin—hematologic cancer	0.0036	0.00366	CcSEcCtD
Bepotastine—Chlorphenamine—SLC22A1—hematologic cancer	0.00357	0.192	CrCbGaD
Bepotastine—Hypersensitivity—Vinorelbine—hematologic cancer	0.00354	0.0036	CcSEcCtD
Bepotastine—Pruritus—Bortezomib—hematologic cancer	0.00348	0.00355	CcSEcCtD
Bepotastine—Rash—Melphalan—hematologic cancer	0.00347	0.00353	CcSEcCtD
Bepotastine—Dermatitis—Melphalan—hematologic cancer	0.00346	0.00353	CcSEcCtD
Bepotastine—Pruritus—Bleomycin—hematologic cancer	0.00345	0.00352	CcSEcCtD
Bepotastine—Pruritus—Vinorelbine—hematologic cancer	0.0034	0.00346	CcSEcCtD
Bepotastine—Hypersensitivity—Thiotepa—hematologic cancer	0.00338	0.00344	CcSEcCtD
Bepotastine—Rash—Lenalidomide—hematologic cancer	0.00337	0.00343	CcSEcCtD
Bepotastine—Dermatitis—Lenalidomide—hematologic cancer	0.00337	0.00343	CcSEcCtD
Bepotastine—Nasopharyngitis—Epirubicin—hematologic cancer	0.00336	0.00342	CcSEcCtD
Bepotastine—Headache—Lenalidomide—hematologic cancer	0.00335	0.00341	CcSEcCtD
Bepotastine—Rash—Hydroxyurea—hematologic cancer	0.00332	0.00339	CcSEcCtD
Bepotastine—Dermatitis—Hydroxyurea—hematologic cancer	0.00332	0.00338	CcSEcCtD
Bepotastine—Headache—Hydroxyurea—hematologic cancer	0.0033	0.00336	CcSEcCtD
Bepotastine—Hypersensitivity—Thalidomide—hematologic cancer	0.00327	0.00333	CcSEcCtD
Bepotastine—Pruritus—Thiotepa—hematologic cancer	0.00324	0.00331	CcSEcCtD
Bepotastine—Hypersensitivity—Carmustine—hematologic cancer	0.00314	0.0032	CcSEcCtD
Bepotastine—Pruritus—Thalidomide—hematologic cancer	0.00314	0.0032	CcSEcCtD
Bepotastine—Hypersensitivity—Alitretinoin—hematologic cancer	0.00311	0.00317	CcSEcCtD
Bepotastine—Nasopharyngitis—Doxorubicin—hematologic cancer	0.00311	0.00317	CcSEcCtD
Bepotastine—Rash—Bortezomib—hematologic cancer	0.0031	0.00316	CcSEcCtD
Bepotastine—Dermatitis—Bortezomib—hematologic cancer	0.0031	0.00316	CcSEcCtD
Bepotastine—Headache—Bortezomib—hematologic cancer	0.00308	0.00314	CcSEcCtD
Bepotastine—Rash—Bleomycin—hematologic cancer	0.00308	0.00314	CcSEcCtD
Bepotastine—Dermatitis—Bleomycin—hematologic cancer	0.00307	0.00313	CcSEcCtD
Bepotastine—Hypersensitivity—Ifosfamide—hematologic cancer	0.00307	0.00313	CcSEcCtD
Bepotastine—Rash—Vinorelbine—hematologic cancer	0.00303	0.00308	CcSEcCtD
Bepotastine—Dermatitis—Vinorelbine—hematologic cancer	0.00302	0.00308	CcSEcCtD
Bepotastine—Headache—Vinorelbine—hematologic cancer	0.00301	0.00307	CcSEcCtD
Bepotastine—Hypersensitivity—Vincristine—hematologic cancer	0.003	0.00305	CcSEcCtD
Bepotastine—Pruritus—Alitretinoin—hematologic cancer	0.00299	0.00304	CcSEcCtD
Bepotastine—Pruritus—Ifosfamide—hematologic cancer	0.00295	0.00301	CcSEcCtD
Bepotastine—Hypersensitivity—Irinotecan—hematologic cancer	0.00292	0.00297	CcSEcCtD
Bepotastine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00292	0.00297	CcSEcCtD
Bepotastine—Rash—Thiotepa—hematologic cancer	0.00289	0.00295	CcSEcCtD
Bepotastine—Dermatitis—Thiotepa—hematologic cancer	0.00289	0.00294	CcSEcCtD
Bepotastine—Headache—Thiotepa—hematologic cancer	0.00287	0.00293	CcSEcCtD
Bepotastine—Rash—Thalidomide—hematologic cancer	0.0028	0.00285	CcSEcCtD
Bepotastine—Dermatitis—Thalidomide—hematologic cancer	0.00279	0.00285	CcSEcCtD
Bepotastine—Headache—Thalidomide—hematologic cancer	0.00278	0.00283	CcSEcCtD
Bepotastine—Pruritus—Gemcitabine—hematologic cancer	0.00273	0.00278	CcSEcCtD
Bepotastine—Rash—Carmustine—hematologic cancer	0.00269	0.00274	CcSEcCtD
Bepotastine—Dermatitis—Carmustine—hematologic cancer	0.00268	0.00273	CcSEcCtD
Bepotastine—Headache—Carmustine—hematologic cancer	0.00267	0.00272	CcSEcCtD
Bepotastine—Rash—Alitretinoin—hematologic cancer	0.00266	0.00271	CcSEcCtD
Bepotastine—Dermatitis—Alitretinoin—hematologic cancer	0.00266	0.00271	CcSEcCtD
Bepotastine—Hypersensitivity—Cisplatin—hematologic cancer	0.00265	0.0027	CcSEcCtD
Bepotastine—Headache—Alitretinoin—hematologic cancer	0.00264	0.00269	CcSEcCtD
Bepotastine—Rash—Ifosfamide—hematologic cancer	0.00263	0.00268	CcSEcCtD
Bepotastine—Dermatitis—Ifosfamide—hematologic cancer	0.00263	0.00268	CcSEcCtD
Bepotastine—Rash—Vincristine—hematologic cancer	0.00256	0.00261	CcSEcCtD
Bepotastine—Dermatitis—Vincristine—hematologic cancer	0.00256	0.00261	CcSEcCtD
Bepotastine—Headache—Vincristine—hematologic cancer	0.00255	0.0026	CcSEcCtD
Bepotastine—Rash—Irinotecan—hematologic cancer	0.0025	0.00254	CcSEcCtD
Bepotastine—Rash—Mitoxantrone—hematologic cancer	0.0025	0.00254	CcSEcCtD
Bepotastine—Dermatitis—Mitoxantrone—hematologic cancer	0.00249	0.00254	CcSEcCtD
Bepotastine—Dermatitis—Irinotecan—hematologic cancer	0.00249	0.00254	CcSEcCtD
Bepotastine—Headache—Irinotecan—hematologic cancer	0.00248	0.00253	CcSEcCtD
Bepotastine—Headache—Mitoxantrone—hematologic cancer	0.00248	0.00253	CcSEcCtD
Bepotastine—Rash—Gemcitabine—hematologic cancer	0.00243	0.00248	CcSEcCtD
Bepotastine—Dermatitis—Gemcitabine—hematologic cancer	0.00243	0.00248	CcSEcCtD
Bepotastine—Hypersensitivity—Etoposide—hematologic cancer	0.00243	0.00247	CcSEcCtD
Bepotastine—Headache—Gemcitabine—hematologic cancer	0.00242	0.00246	CcSEcCtD
Bepotastine—Hypersensitivity—Prednisolone—hematologic cancer	0.00239	0.00244	CcSEcCtD
Bepotastine—Pruritus—Etoposide—hematologic cancer	0.00233	0.00237	CcSEcCtD
Bepotastine—Rash—Cisplatin—hematologic cancer	0.00227	0.00231	CcSEcCtD
Bepotastine—Dermatitis—Cisplatin—hematologic cancer	0.00227	0.00231	CcSEcCtD
Bepotastine—Hypersensitivity—Triamcinolone—hematologic cancer	0.0022	0.00224	CcSEcCtD
Bepotastine—Pruritus—Triamcinolone—hematologic cancer	0.00211	0.00215	CcSEcCtD
Bepotastine—Rash—Etoposide—hematologic cancer	0.00208	0.00212	CcSEcCtD
Bepotastine—Dermatitis—Etoposide—hematologic cancer	0.00208	0.00211	CcSEcCtD
Bepotastine—Headache—Etoposide—hematologic cancer	0.00206	0.0021	CcSEcCtD
Bepotastine—Rash—Prednisolone—hematologic cancer	0.00205	0.00209	CcSEcCtD
Bepotastine—Dermatitis—Prednisolone—hematologic cancer	0.00205	0.00209	CcSEcCtD
Bepotastine—Headache—Prednisolone—hematologic cancer	0.00204	0.00207	CcSEcCtD
Bepotastine—Pruritus—Dexamethasone—hematologic cancer	0.00192	0.00195	CcSEcCtD
Bepotastine—Pruritus—Betamethasone—hematologic cancer	0.00192	0.00195	CcSEcCtD
Bepotastine—Rash—Triamcinolone—hematologic cancer	0.00188	0.00192	CcSEcCtD
Bepotastine—Dermatitis—Triamcinolone—hematologic cancer	0.00188	0.00192	CcSEcCtD
Bepotastine—Headache—Triamcinolone—hematologic cancer	0.00187	0.00191	CcSEcCtD
Bepotastine—Hypersensitivity—Prednisone—hematologic cancer	0.00174	0.00177	CcSEcCtD
Bepotastine—Rash—Dexamethasone—hematologic cancer	0.00171	0.00174	CcSEcCtD
Bepotastine—Rash—Betamethasone—hematologic cancer	0.00171	0.00174	CcSEcCtD
Bepotastine—Dermatitis—Betamethasone—hematologic cancer	0.00171	0.00174	CcSEcCtD
Bepotastine—Dermatitis—Dexamethasone—hematologic cancer	0.00171	0.00174	CcSEcCtD
Bepotastine—Headache—Betamethasone—hematologic cancer	0.0017	0.00173	CcSEcCtD
Bepotastine—Headache—Dexamethasone—hematologic cancer	0.0017	0.00173	CcSEcCtD
Bepotastine—Pruritus—Prednisone—hematologic cancer	0.00167	0.0017	CcSEcCtD
Bepotastine—Fexofenadine—ABCB1—hematologic cancer	0.0015	0.0807	CrCbGaD
Bepotastine—Rash—Prednisone—hematologic cancer	0.00149	0.00152	CcSEcCtD
Bepotastine—Dermatitis—Prednisone—hematologic cancer	0.00149	0.00152	CcSEcCtD
Bepotastine—Headache—Prednisone—hematologic cancer	0.00148	0.00151	CcSEcCtD
Bepotastine—Hypersensitivity—Methotrexate—hematologic cancer	0.00145	0.00148	CcSEcCtD
Bepotastine—Pruritus—Methotrexate—hematologic cancer	0.0014	0.00142	CcSEcCtD
Bepotastine—Domperidone—ABCB1—hematologic cancer	0.00137	0.0737	CrCbGaD
Bepotastine—Hypersensitivity—Epirubicin—hematologic cancer	0.00136	0.00139	CcSEcCtD
Bepotastine—Pruritus—Epirubicin—hematologic cancer	0.00131	0.00133	CcSEcCtD
Bepotastine—Hypersensitivity—Doxorubicin—hematologic cancer	0.00126	0.00128	CcSEcCtD
Bepotastine—Rash—Methotrexate—hematologic cancer	0.00124	0.00127	CcSEcCtD
Bepotastine—Dermatitis—Methotrexate—hematologic cancer	0.00124	0.00127	CcSEcCtD
Bepotastine—Headache—Methotrexate—hematologic cancer	0.00124	0.00126	CcSEcCtD
Bepotastine—Pruritus—Doxorubicin—hematologic cancer	0.00121	0.00123	CcSEcCtD
Bepotastine—Rash—Epirubicin—hematologic cancer	0.00116	0.00119	CcSEcCtD
Bepotastine—Dermatitis—Epirubicin—hematologic cancer	0.00116	0.00119	CcSEcCtD
Bepotastine—Headache—Epirubicin—hematologic cancer	0.00116	0.00118	CcSEcCtD
Bepotastine—Rash—Doxorubicin—hematologic cancer	0.00108	0.0011	CcSEcCtD
Bepotastine—Dermatitis—Doxorubicin—hematologic cancer	0.00108	0.0011	CcSEcCtD
Bepotastine—Headache—Doxorubicin—hematologic cancer	0.00107	0.00109	CcSEcCtD
Bepotastine—Haloperidol—ABCB1—hematologic cancer	0.00104	0.0562	CrCbGaD
Bepotastine—Fentanyl—ABCB1—hematologic cancer	0.000991	0.0533	CrCbGaD
